Bollard Group LLC Amgen Inc Transaction History

Bollard Group LLC

$3.76 Billion
Q3 2024

A detailed history of Bollard Group LLC transactions in Amgen Inc stock. As of the latest transaction made, Bollard Group LLC holds 3,625 shares of AMGN stock, worth $952,106. This represents 0.03% of its overall portfolio holdings.

Number of Shares

3,625

Previous 3,600 0.69%

Holding current value

$952,106

Previous $1.13 Million 3.82%

% of portfolio

0.03%

Previous 0.03%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$309.38 - $337.38 $7,734 - $8,434	25 Added 0.69%	3,625 $1.17 Million
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $6,831 - $8,302	26 Added 0.73%	3,600 $1.13 Million
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $7,797 - $9,412	29 Added 0.82%	3,574 $1.02 Million
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $6,903 - $7,788	27 Added 0.77%	3,545 $1.02 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $3,279 - $4,071	-15 Reduced 0.42%	3,518 $945,000
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $16,713 - $19,762	78 Added 2.26%	3,533 $784,000
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $7,225 - $8,806	32 Added 0.93%	3,455 $835,000
Q4 2022 Feb 10, 2023	BUY	$229.03 - $291.01 $5,267 - $6,693	23 Added 0.68%	3,423 $899,000
Q3 2022 Nov 09, 2022	BUY	$224.46 - $253.15 $6,060 - $6,835	27 Added 0.8%	3,400 $766,000
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $5,998 - $6,675	26 Added 0.78%	3,373 $821,000
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $5,920 - $6,549	27 Added 0.81%	3,347 $809,000
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $5,568 - $6,372	28 Added 0.85%	3,320 $747,000
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $5,519 - $6,466	26 Added 0.8%	3,292 $700,000
Q2 2021 Aug 12, 2021	BUY	$233.58 - $259.14 $5,605 - $6,219	24 Added 0.74%	3,266 $796,000
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $641,300 - $786,963	3,242 New	3,242 $765,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $140B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bollard Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bollard Group LLC with notifications on news.

Account

Bollard Group LLC Amgen Inc Transaction History